6-Month Multicenter Randomized Open-Label Parallel-Group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus both plus Mealtime Insulin in Patients with Type 2 Diabetes Mellitus with a 6-Month Safety Extension P
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This study is being done to compare the effectiveness, safety and tolerability of a newly developed formulation of insulin.
Description
This study is being done to compare the effectiveness, safety and tolerability of a newly developed formulation of insulin.
Details
| Condition | Diabetes - Type II |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX2498 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.